EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
23,444,245
Total 13F shares
10,800,916
Share change
+1,356,086
Total reported value
$65,665,424
Price per share
$6.08
Number of holders
80
Value change
+$3,624,882
Number of buys
56
Number of sells
24

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2025

As of 31 Dec 2025, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,800,916 shares. The largest 10 holders included Balyasny Asset Management L.P., RTW INVESTMENTS, LP, VANGUARD GROUP INC, SILVERCREST ASSET MANAGEMENT GROUP LLC, KENNEDY CAPITAL MANAGEMENT LLC, WEXFORD CAPITAL LP, ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, Mink Brook Asset Management LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 80 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.